-logo-1200x675.png?v=20240521153233&w=240&h=240&zc=2){kind=logo}
Viridian Therapeutics, Inc. (NASDAQ:VRDN) Stock Position Increased by Barclays PLC
Barclays PLC lifted its position in Viridian Therapeutics, Inc. (NASDAQ:VRDN – Free Report) by 25.9% during the fourth quarter, Holdings Channel reports. The institutional investor owned 157,860 shares of the company’s stock after buying an additional 32,463 shares during the quarter. Barclays PLC’s holdings in Viridian Therapeutics were worth $3,027,000 at the end of the […]
Barclays PLC lifted its position in Viridian Therapeutics, Inc. (NASDAQ:VRDN – Free Report) by 25.9% during the fourth quarter, Holdings Channel reports. The institutional investor owned 157,860 shares of the company’s stock after buying an additional 32,463 shares during the quarter. Barclays PLC’s holdings in Viridian Therapeutics were worth $3,027,000 at the end of the […]
